Chiron has submitted a mock-up dossier that seeks outline approval to market a pandemic flu vaccine. Under European guidelines, a drug maker can file a mock-up vaccine in advance of an outbreak. Once the outbreak occurs, the drug maker modifies the application with the strain that is responsible for a pandemic. Chiron is the second biopharma company to file for outline approval. GlaxoSmithKline filed last December.
- here's the report from AFX for more information
ALSO: Niger has confirmed finding the H5N1 virus in a small village. Health officials believe the virus is likely to spread rapidly in Africa, a continent with few resources to combat the spread of disease. Report